ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 403

Cardiac Immune Cells in SKG Mice with Inflammatory Arthritis before and after Myocardial Infarction

Christine Hsieh1, Isabella Imhof2, Luyi Li3, Erene Niemi1, Matthew Bell1, Joel Karliner4 and Mary Nakamura5, 1Medicine, SFVA/UCSF, San Francisco, CA, 2Medicine, SFVA/NCIRE, San Francisco, CA, 3SFVA/UCSF, San Francisco, CA, 4Medicine, SFVA/UCSF, San, CA, 5Department of Medicine, Division of Rheumatology, UCSF/SFVA, San Francisco, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, innate immunity, macrophages and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Animal Models Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Cardiovascular disease is a major cause of morbidity and mortality in patients with rheumatoid arthritis (RA). RA patients have an increased incidence of both myocardial infarction (MI) and congestive heart failure. Cardiac immune cells have been demonstrated to influence cardiac remodeling post infarction and our study examined the effect of inflammatory arthritis on cardiac immune cells using a mouse model of myocardial infarction in SKG mice, a model of inflammatory arthritis.

Methods:

Arthritis was induced in female SKG mice (BALB/c ZAP-70W163C-mutants) with a single injection of zymosan at 12 weeks age and were examined after development of athritis at 4 weeks. Wild type Balb/c mice, SKG mice, and SKG mice with arthritis (4 weeks post-zymosan) with MI underwent permanent left anterior descending coronary artery ligation. Cardiac leukocytes were evaluated at day 1 and 6 post-infarction, following harvest with cardiac perfusion, disaggregation of the heart, collagenase digestion, cellular isolation and antibody staining for multicolor flow cytometry. Cells were analyzed using a FACS Aria and FlowJo software (hearts were analyzed individually, 5 mice per group) using lineage markers (CD90/CD19/NK1.1/Ly-6G) to evaluate T cells, B cells, NK cells, granulocytes and myeloid markers CD11b, F4/80, Ly-6C.

Results:

Hearts isolated from SKG mice without arthritis showed a slight increase in the number of cardiac neutrophils compared with wild type Balb/c, that was increased by 3-4 fold in SKG mice with arthritis. At baseline SKG mice with arthritis also had a 2-3 fold increase in inflammatory macrophages (Ly6C+) compared with either SKG or Balb/c mice. Hearts isolated from SKG mice with arthritis 1 day post MI, showed a 5-6 fold increase in Ly6G+ cells (neutrophils) and Ly6C+/CD11b (monocyte/macrophages) cells compared to the basal numbers seen in hearts isolated from wild-type Balb/c mice. At day 6, SKG mice and SKG mice with arthritis both showed a persistent increase in Ly-6C+ macrophages compared with the decrease in these cells observed in Balc/c mice at the same time point. Functional outcomes post-MI correlated with these changes are currently being evaluated.

Conclusion:

We found that inflammatory arthritis induces changes in the number and phenotype of cardiac immune cells in mice both before and after myocardial infarction which likely influences cardiac repair and ventricular remodeling post-MI contibuting to detrimental cardiac outcomes with inflammatory arthritis.


Disclosure: C. Hsieh, None; I. Imhof, None; L. Li, None; E. Niemi, None; M. Bell, None; J. Karliner, None; M. Nakamura, None.

To cite this abstract in AMA style:

Hsieh C, Imhof I, Li L, Niemi E, Bell M, Karliner J, Nakamura M. Cardiac Immune Cells in SKG Mice with Inflammatory Arthritis before and after Myocardial Infarction [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/cardiac-immune-cells-in-skg-mice-with-inflammatory-arthritis-before-and-after-myocardial-infarction/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiac-immune-cells-in-skg-mice-with-inflammatory-arthritis-before-and-after-myocardial-infarction/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology